litlas
Log inCreate account

Winnie Yeo

Active 1995–2024

77
Papers
19,710
Citations
62
h-index
77
i10-index

Citations

Citations per year for Winnie Yeo1977: 1 citations1993: 1 citations1994: 1 citations1996: 2 citations1997: 4 citations1998: 4 citations1999: 2 citations2000: 7 citations2001: 29 citations2002: 49 citations2003: 42 citations2004: 68 citations2005: 70 citations2006: 69 citations2007: 78 citations2008: 114 citations2009: 88 citations2010: 115 citations2011: 95 citations2012: 115 citations2013: 90 citations2014: 85 citations2015: 136 citations2016: 129 citations2017: 163 citations2018: 212 citations2019: 814 citations2020: 949 citations2021: 937 citations2022: 598 citations2023: 481 citations2024: 725 citations2025: 309 citations2026: 3 citations1978–1992: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,106 citing papers, 23.3% of this breakdownUnited States: 1,583 citing papers, 17.5% of this breakdownJapan: 560 citing papers, 6.2% of this breakdownItaly: 482 citing papers, 5.3% of this breakdownGermany: 370 citing papers, 4.1% of this breakdownHong Kong: 366 citing papers, 4% of this breakdownTaiwan: 364 citing papers, 4% of this breakdownUnited Kingdom: 330 citing papers, 3.6% of this breakdownFrance: 313 citing papers, 3.5% of this breakdownSouth Korea: 296 citing papers, 3.3% of this breakdownSpain: 273 citing papers, 3% of this breakdownCanada: 200 citing papers, 2.2% of this breakdown
0%23.3%Other 20%

Institutions

Fields

  • Medicine79.9%
  • Biochemistry, Genetics and Molecular Biology13.4%
  • Immunology and Microbiology4.2%
  • Engineering0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • Materials Science0.3%
  • Other1.5%

Topics

  • Hepatocellular Carcinoma Treatment and Prognosis14.2%
  • Cancer Immunotherapy and Biomarkers7.2%
  • Liver Disease Diagnosis and Treatment5.4%
  • Hepatitis B Virus Studies4.5%
  • Cholangiocarcinoma and Gallbladder Cancer Studies3.4%
  • Hepatitis C virus research3.2%
  • Other62.1%

Coauthors

All papers

Open in search
  1. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

    Authors: Anthony B. El-Khoueiry, Bruno Sangro, Thomas Yau, Todd S. Crocenzi, Masatoshi Kudo, Chiun Hsu, Tae‐You Kim, Su-Pin Choo, Jörg Trojan, Theodore H. Welling, Tim Meyer, Yoon‐Koo Kang, Winnie Yeo, Akhil Chopra, Jeffrey Anderson, Christine Dela Cruz, Lixin Lang, Jaclyn Neely, Hao Tang, Homa Dastani, Ignacio Melero - The Lancet 2017 cited by 4,315

  2. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

    Authors: Sara A. Hurvitz, Roberto Hegg, Wei‐Pang Chung, Seock‐Ah Im, William Jacot, Vinod Ganju, Joanne Wing Yan Chiu, Binghe Xu, Erika Hamilton, Srinivasan Madhusudan, Hiroji Iwata, Sevilay Altıntaş, Jan‐Willem Henning, Giuseppe Curigliano, José Manuel Pérez-García, Sung‐Bae Kim, Vanessa Petry, Chiun‐Sheng Huang, Wěi Li, Jean‐Sébastien Frenel, Silvia Antolín, Winnie Yeo, Giampaolo Bianchini, Sherene Loi, Junji Tsurutani, Anton Egorov, Yali Liu, Jillian Cathcart, Shahid Ashfaque, Javier Cortés - The Lancet 2022 cited by 642

  3. Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

    Authors: Philip J. Johnson, Sarah Berhane, Chiaki Kagebayashi, Shinji Satomura, Mabel Teng, Helen L. Reeves, James O’Beirne, Richard Fox, Anna Skowrońska, Daniel H. Palmer, Winnie Yeo, Frankie Mo, Paul B.S. Lai, Mercedes Iñarrairaegui, Stephen L. Chan, Bruno Sangro, Rebecca A. Miksad, Toshifumi Tada, Takashi Kumada, Hidenori Toyoda - Journal of Clinical Oncology 2014 cited by 2,755

  4. Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

    Authors: Sarah Berhane, Hidenori Toyoda, Toshifumi Tada, Takashi Kumada, Chiaki Kagebayashi, Shinji Satomura, Nóra Schweitzer, Arndt Vogel, Michael P. Manns, Julia Benckert, Thomas Berg, Maria Ebker, Jan Best, Alexander Dechêne, Guido Gerken, JF Schlaak, Arndt Weinmann, Marcus A. Wörns, Peter R. Galle, Winnie Yeo, Frankie Mo, Stephen L. Chan, Helen L. Reeves, Trevor F. Cox, Philip J. Johnson - Clinical Gastroenterology and Hepatology 2016 cited by 323

  5. Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040

    Authors: Anthony B. El-Khoueiry, Jörg Trojan, Tim Meyer, Thomas Yau, Ignacio Melero, Masatoshi Kudo, Chih‐Hung Hsu, T.-Y. Kim, Su Pin Choo, Yubin Kang, Winnie Yeo, Akhil Chopra, Samira Soleymani, J. Yao, Jaclyn Neely, Marina Tschaika, Theodore H. Welling, Bruno Sangro - Annals of Oncology 2023 cited by 63

  6. Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

    Authors: Vincent Wai‐Sun Wong, Stephen L. Chan, Frankie Mo, Tung-Ching Chan, Herbert H. Loong, Grace Lai‐Hung Wong, Yanni Yan-Ni Lui, Anthony T.�C. Chan, Joseph J.�Y. Sung, Winnie Yeo, Henry Lik‐Yuen Chan, Tony Mok - Journal of Clinical Oncology 2010 cited by 503

  7. Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

    Authors: Thomas Yau, Chiun Hsu, Tae‐You Kim, Su-Pin Choo, Yoon‐Koo Kang, Ming‐Mo Hou, Kazushi Numata, Winnie Yeo, Akhil Chopra, Masafumi Ikeda, Ryoko Kuromatsu, Michihisa Moriguchi, Yee Chao, Huanyu Zhao, Jeffrey Anderson, Christine Dela Cruz, Masatoshi Kudo - Journal of Hepatology 2019 cited by 269

  8. A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma

    Authors: Winnie Yeo, Tony Mok, Benny Zee, Thomas W. T. Leung, Paul B.S. Lai, Wan Yee Lau, Jane Koh, Frankie Mo, Simon C.H. Yu, Anthony T.�C. Chan, Pun Hui, Brigette Ma, Kwok Chi Lam, Wing Ming Ho, Herman Wong, Amanda M. Y. Tang, Philip J. Johnson - JNCI Journal of the National Cancer Institute 2005 cited by 589

  9. Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

    Authors: Winnie Yeo, Tung Ching Chan, Nancy Leung, Wai Yip Lam, Frankie Mo, Miu Ting Chu, Henry Lik‐Yuen Chan, Edwin P. Hui, Kenny I. K. Lei, Tony Mok, Paul K.S. Chan - Journal of Clinical Oncology 2008 cited by 633

  10. A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy

    Authors: Alex Molassiotis, Lorna Kwai Ping Suen, Huilin Cheng, Tony Mok, Sara C. Y. Lee, C. H. Wang, Paul H. Lee, Howan Leung, Victor Chan, Tracy Lau, Winnie Yeo - Integrative Cancer Therapies 2019 cited by 109

  11. Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel

    Authors: Joanne Chiu, Soo Chin Lee, Jcm Ho, Yeon Hee Park, Ta‐Chung Chao, Sung‐Bae Kim, Elgene Lim, Ching‐Hung Lin, Sherene Loi, Su Ying Low, Lynette Teo, Winnie Yeo, Rebecca Dent - Drug Safety 2023 cited by 31

  12. Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group

    Authors: Winnie Yeo, Hyun Cheol Chung, Stephen L. Chan, Ling Z. Wang, Robert Lim, Joel Picus, Michael Boyer, Frankie Mo, Jane Koh, Sun Young Rha, Edwin P. Hui, Hei Cheul Jeung, Jae Kyung Roh, Simon C.H. Yu, Ka‐Fai To, Qian Tao, Brigette Ma, Anthony W.H. Chan, Joanna H.M. Tong, Charles Erlichman, Anthony T.�C. Chan, Boon Cher Goh - Journal of Clinical Oncology 2012 cited by 195

  13. Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population

    Authors: Ching‐Hung Lin, Yoon Sim Yap, Kyung-Hun Lee, Seock‐Ah Im, Yoichi Naito, Winnie Yeo, Takayuki Ueno, Ava Kwong, Huiping Li, Shu‐Min Huang, Roland Leung, Wonshik Han, Benita Kiat Tee Tan, Fu‐Chang Hu, Chiun‐Sheng Huang, Ann‐Lii Cheng, Yen‐Shen Lu, The Asian Breast Cancer Cooperative Group - JNCI Journal of the National Cancer Institute 2019 cited by 114

  14. A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma

    Authors: Stephen L. Chan, Paul N. Cheng, Angela M. Liu, Landon L. Chan, Leung Li, Cheuk Man Chu, Charing C. N. Chong, Yat M. Lau, Winnie Yeo, Kelvin K. Ng, Simon C.H. Yu, Tony Mok, Anthony W.H. Chan - Investigational New Drugs 2021 cited by 45

  15. Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma

    Authors: Ho Yeong Lim, Philippe Merle, Karl Weiss, Thomas Yau, Paul J. Ross, Vincenzo Mazzaferro, Jean‐Frédéric Blanc, Yuk Ting, Chia Jui Yen, Judit Kocsis, Su Pin Choo, Wattana Sukeepaisarnjaroen, René Gerolami, Jean‐François Dufour, Edward Gane, Baek‐Yeol Ryoo, Markus Peck‐Radosavljevic, Thông Dao, Winnie Yeo, Wisut Lamlertthon, Satawat Thongsawat, Michael Teufel, Katrin Roth, Diego Reis, Barrett H. Childs, Heiko Krissel, Josep M. Llovet - Clinical Cancer Research 2018 cited by 82

  16. Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma

    Authors: Qian Zhou, Vivian Wai Yan Lui, Winnie Yeo - Future Oncology 2011 cited by 215

  17. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors

    Authors: Winnie Yeo, Paul K.S. Chan, Sheng Zhong, Wing Ming Ho, Joyce Steinberg, John S. Tam, Pun Hui, Nancy W.Y. Leung, Benny Zee, Philip J. Johnson - Journal of Medical Virology 2000 cited by 628

  18. Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma

    Authors: Anthony T.�C. Chan, S. F. Leung, Roger KC Ngan, Peter M. L. Teo, W.H. Lau, W. H. Kwan, Esk Hui, H. Y. Yiu, Winnie Yeo, Fan Cheung, Kam Yu, K.W. Chiu, Danny Chan, Tony Mok, Stephen S.‐T. Yau, Kam‐Tong Yuen, Frankie Mo, Minh Lại, Brigette Ma, Michael Kam, Thomas W. T. Leung, P J Johnson, Peter H.K. Choi, Benny Zee - JNCI Journal of the National Cancer Institute 2005 cited by 521

  19. Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response

    Authors: Winnie Yeo, Stephen L. Chan, Frankie Mo, Cheuk Man Chu, J. Hui, Joanne HM Tong, Anthony W.H. Chan, Jane Koh, Edwin P. Hui, Herbert H. Loong, Kirsty Lee, Leung Li, Brigette Ma, Ka‐Fai To, Simon C.H. Yu - BMC Cancer 2015 cited by 134

  20. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.

    Authors: I H Wong, Y M Lo, Winnie Yeo, Wan Yee Lau, Philip E. Johnson - 2000 cited by 190

  21. Validation of the Chinese version of the Short‐form Supportive Care Needs Survey Questionnaire (SCNS‐SF34‐C)

    Authors: Angel Hoe-chi Au, Wwt Lam, Ava Kwong, Dacita Suen, Janice Tsang, Winnie Yeo, Joyce Suen, WM Ho, T. Yau, Inda Soong, Ka Yan Wong, Wai-Man Sze, Aik Seng Ng, Afaf Girgis, R Fielding - Psycho-Oncology 2010 cited by 101

  22. Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

    Authors: Anthony T.�C. Chan, P. Teo, Roger K.C. Ngan, Thomas W. T. Leung, W.H. Lau, Benny Zee, S. F. Leung, Fan Cheung, Winnie Yeo, Harry Yiu, Kam Yu, K.W. Chiu, Danny Chan, Tony Mok, Kam‐Tong Yuen, Frankie Mo, Simon Lai, W. H. Kwan, Peter Choi, Philip J. Johnson - Journal of Clinical Oncology 2002 cited by 482

  23. New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

    Authors: Stephen L. Chan, Frankie Mo, Philip J. Johnson, Edwin P. Hui, Brigette Ma, Wing Ming Ho, Kwok Chi Lam, Anthony T.�C. Chan, Tony Mok, Winnie Yeo - Journal of Clinical Oncology 2008 cited by 253

  24. Phase II Study of Neoadjuvant Carboplatin and Paclitaxel Followed by Radiotherapy and Concurrent Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: Therapeutic Monitoring With Plasma Epstein-Barr Virus DNA

    Authors: Anthony T.�C. Chan, Brigette Ma, Yuk Ming Dennis Lo, S. F. Leung, W. H. Kwan, Edwin P. Hui, Tony Mok, Michael Kam, L.S. Chan, Samuel K.W. Chiu, Kam Yu, K.Y. Cheung, Karen Lai, Maria Lai, Frankie Mo, Winnie Yeo, Ann D. King, Philip J. Johnson, Peter M.L. Teo, Benny Zee - Journal of Clinical Oncology 2004 cited by 135